Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy

The utility of multigene expression assays in advanced (≥ 4 positive lymph nodes) early breast cancer (EBC) is limited. We conducted exploratory transcriptomic analysis of 758 genes (Breast Cancer 360 panel, nCounter® platform; NanoString) in primary tumor samples collected during a phase 3 trial co...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Mattea Reinisch, Simona Bruzas, Oleg Gluz, Beyhan Ataseven, Peter Schmid, Javier Cortés, Jens‐Uwe Blohmer, Satyendra Shenoy, Mark H. Dyson, Christine Dittmer‐Grabowski, Ouafaa Chiari, Hakima Harrach, Daniel Gebauer, Alexander Traut, Sherko Kuemmel
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2023-06-01
Schriftenreihe:	Molecular Oncology
Schlagworte:	adjuvant chemotherapy dose‐dense chemotherapy early breast cancer gene signature lymph node‐positive
Online-Zugang:	https://doi.org/10.1002/1878-0261.13435
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!